resili on-going pandem
conduct analyst
govern code ethics/cod conduct
polici secur trade polici
equival invest research
interest visit
primari analyst cover compani
stock
research may
estim apr
price data may
rate updat may
currenc amount express
methodolog valu compani
narrow-moat impress finish fiscal
exceed expect revenu profit
beat market consensu ep compil capit iq
previous reduc fair valu estim light
on-going pandem maintain current
fair valu estim per share plan review
model assumpt detail get clariti
impact next quarter
maintain momentum fiscal anticip
increas fair valu estim though expect
valuat chang low- mid-single-digit rang
near plung share price late march
market come around view long-
term outlook rel unaffect pandem
share trade upward fairli valu
opinion trade intrins valu much
report full-year revenu billion net
incom million over-perform
even compar bull-cas estim final
quarter though segment held rel well
healthcar specialti organ growth contract
appli steril growth particularli strong
continu think appli steril account
materi portion futur oper incom growth given
high growth level alreadi signific base
robust margin busi segment achiev
margin quarter equal high-wat
mark first fiscal quarter continu
expect long-term segment margin greater
double-digit growth five-year explicit
forecast materi driver valuat
anticip limit impact life scienc
segment tie less-expos pharmaceut sector
valuat summari forecast
financi summari forecast
historical/forecast data sourc morningstar estim may reflect adjust
 -base medic devic compani focus steril
servic infect prevent compani global leader
contract steril servic ensur safe deliveri single-us
implant medic equip hospit around world addit
sell steril washer-disinfector decontamin
equip suppli use care provid facil biopharma
manufactur site domicil unit state
invers firm continu deriv roughli revenu
oper unit kingdom remain
intern region
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
trend go forward new segment simpli call
healthcar account major revenu ebit
expect consolid dilut report profit
healthcar product given lower margin higher
level invest previous attribut healthcar
resili first month crisi
give credenc view compani benefit
averag cyclic updat take
publish decemb lower cost equiti
model account lower cyclic drove
bulk valuat upgrad under-valued call
context worst fiscal year came financi
crisi sale fell approxim
time revenu capit equip
three quarter sale relat more-dur
financi situat hospit put pressur capit
equip fiscal earli calendar
expect consum rebound near-norm level within
next two quarter surgeri procedur start
return pre-pandem level
pleas see strong growth
constant currenc sale healthcar product
weakest link busi revenu
flat exclud impact acquisit expect
segment post neg growth first part
fiscal year model full-year growth impact
neg segment note howev
challeng partial off-set
durabl life scienc appli contract
busi rebound later year
resumpt surgic procedur bring growth back
near-norm level
full-year fiscal came guidanc
ahead expect guidanc issu
fiscal high degre uncertainti relat
on-going pandem earn call manag
emphas difficulti forecast busi outcom
amid uncertainti creat pandem despit
pull guidanc appear track ahead
long-term outlook revenu growth rang
exclud temporari impact pandem came
away call confid long-term
expect top-lin growth rang slightli
ahead manag conserv baselin
addit report fourth-quart end-year result
announc consolid healthcar
product healthcar specialti servic segment
previous account revenu
respect oper incom
earn call manag mention becom
difficult distinguish revenu segment
custom overlap consolid intern
process give us concern valid
previous report result histor segment data may
accur reflect business-level growth earn
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
financi summari forecast
fiscal year end march
earn interest tax
return asset
return equiti
valuat summari forecast
equiti
pre-tax debt
weight averag capit
addit estim scenario avail download http //select morningstar com
equival
data tabl repres base-cas forecast compani report
currenc begin current year fair valu estim may differ
equiti valu per share shown due time valu money adjust case
probability-weight scenario analysi perform
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
fiscal year end march
good sold
depreci amort report separ
impair charg report separ
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
